258 related articles for article (PubMed ID: 28711607)
1. Epigenetics of pituitary tumors: Pathogenetic and therapeutic implications.
Ezzat S; Cheng S; Asa SL
Mol Cell Endocrinol; 2018 Jul; 469():70-76. PubMed ID: 28711607
[TBL] [Abstract][Full Text] [Related]
2. Chromatin remodeling and histone modifications in pituitary tumors.
Tateno T; Zhu X; Asa SL; Ezzat S
Mol Cell Endocrinol; 2010 Sep; 326(1-2):66-70. PubMed ID: 20060434
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic control in pituitary tumors.
Ezzat S
Endocr J; 2008 Dec; 55(6):951-7. PubMed ID: 18628575
[TBL] [Abstract][Full Text] [Related]
4. Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications.
Silverman BR; Shi J
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999365
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk among epigenetic modifications: lessons from histone arginine methylation.
Molina-Serrano D; Schiza V; Kirmizis A
Biochem Soc Trans; 2013 Jun; 41(3):751-9. PubMed ID: 23697934
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic mechanisms in gastric cancer.
Gigek CO; Chen ES; Calcagno DQ; Wisnieski F; Burbano RR; Smith MA
Epigenomics; 2012 Jun; 4(3):279-94. PubMed ID: 22690664
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
Herranz M; Esteller M
Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
[TBL] [Abstract][Full Text] [Related]
8. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells.
Kitchen MO; Yacqub-Usman K; Emes RD; Richardson A; Clayton RN; Farrell WE
Pituitary; 2015 Oct; 18(5):674-84. PubMed ID: 25557289
[TBL] [Abstract][Full Text] [Related]
9. Histone modification: cause or cog?
Henikoff S; Shilatifard A
Trends Genet; 2011 Oct; 27(10):389-96. PubMed ID: 21764166
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation and chromatin modifiers in colorectal cancer.
Vymetalkova V; Vodicka P; Vodenkova S; Alonso S; Schneider-Stock R
Mol Aspects Med; 2019 Oct; 69():73-92. PubMed ID: 31028771
[TBL] [Abstract][Full Text] [Related]
11. Epigenome dysregulation in cholangiocarcinoma.
O'Rourke CJ; Munoz-Garrido P; Aguayo EL; Andersen JB
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1423-1434. PubMed ID: 28645654
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic interplay of histone modifications and DNA methylation mediated by HDA6.
Liu X; Luo M; Wu K
Plant Signal Behav; 2012 Jun; 7(6):633-5. PubMed ID: 22580702
[TBL] [Abstract][Full Text] [Related]
13. Histone Modifications in Aging: The Underlying Mechanisms and Implications.
Wang Y; Yuan Q; Xie L
Curr Stem Cell Res Ther; 2018; 13(2):125-135. PubMed ID: 28820059
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic targeting for acute kidney injury.
Zhuang S
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():21-25. PubMed ID: 30298650
[TBL] [Abstract][Full Text] [Related]
15. Progress in Epigenetics of Depression.
Peña CJ; Nestler EJ
Prog Mol Biol Transl Sci; 2018; 157():41-66. PubMed ID: 29933956
[TBL] [Abstract][Full Text] [Related]
16. [Epigenetic modifications in lung cancer].
Brambilla E
Ann Pathol; 2009 Nov; 29 Spec No 1():S31-3. PubMed ID: 19887246
[No Abstract] [Full Text] [Related]
17. Nucleotide Metabolism Behind Epigenetics.
Suganuma T; Workman JL
Front Endocrinol (Lausanne); 2021; 12():731648. PubMed ID: 34526971
[TBL] [Abstract][Full Text] [Related]
18. On the role of retinoblastoma family proteins in the establishment and maintenance of the epigenetic landscape.
Fiorentino FP; Marchesi I; Giordano A
J Cell Physiol; 2013 Feb; 228(2):276-84. PubMed ID: 22718354
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic processes in sporadic parathyroid neoplasms.
Silva-Figueroa AM; Perrier ND
Mol Cell Endocrinol; 2018 Jul; 469():54-59. PubMed ID: 28400272
[TBL] [Abstract][Full Text] [Related]
20. The roles of epigenetics in cancer progression and metastasis.
Chen JF; Yan Q
Biochem J; 2021 Sep; 478(17):3373-3393. PubMed ID: 34520519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
